本文へ移動
cccskills
無料GitHub で公開

es-cushing-glucocorticoid-replacement-education-hypocortisolemic

This skill recommends glucocorticoid replacement and patient education for hypocortisolemic patients after surgical remission of Cushing's syndrome. Use when a postoperative Cushing's patient exhibits low cortisol (e.g., morning cortisol <5 µg/dL) or symptoms of adrenal insufficiency.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.9 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Glucocorticoid Replacement and Education for Hypocortisolemic Patients After Surgical Remission

STEP 1 — Gather Information

Collect postoperative timing, type of surgery (pituitary vs adrenal), morning serum cortisol (or UFC), symptoms of adrenal insufficiency (fatigue, weight loss, nausea, hypotension, hypoglycemia), prior glucocorticoid dose, and presence of at least one intact adrenal gland.
Action: Document cortisol value and clinical picture to assess for hypocortisolism.

STEP 2 — Rule In / Rule Out

Rule in adrenal insufficiency if morning cortisol <5 µg/dL (<138 nmol/L) or symptomatic with low/low-normal cortisol; rule out if morning cortisol ≥5 µg/dL and asymptomatic.
Action: Proceed to classification if adrenal insufficiency is suspected.

STEP 3 — Classify or Stratify

Classify as confirmed hypocortisolism requiring replacement if low cortisol persists with symptoms or if post‑bilateral adrenalectomy; classify as transient low cortisol if asymptomatic and cortisol borderline, needing repeat testing in 4–6 weeks.
Action: Determine need for immediate glucocorticoid replacement.

STEP 4 — Decide

If confirmed hypocortisolism, initiate physiologic hydrocortisone replacement (10–12 mg/m²/day divided 2–3 doses, first dose on waking) and provide education on stress dosing, medical alert tag, and signs of adrenal crisis.
Action: Start replacement and education; schedule follow‑up cortisol/ACTH stimulation testing in 3–6 months to assess HPA‑axis recovery.

Clinical Guardrails / Mimics / Pitfalls

Avoid over‑replacement that causes iatrogenic Cushing features; do not discontinue glucocorticoids prematurely before HPA‑axis recovery (risk of adrenal crisis); distinguish glucocorticoid withdrawal symptoms (fatigue, myalgias) from disease recurrence by checking cortisol trends and clinical context.

Concrete Clinical Example

A 48‑year‑old man 8 weeks after bilateral adrenalectomy for Cushing’s disease has morning cortisol 2 µg/dL, mild nausea, and fatigue. He is started on hydrocortisone 10 mg AM, 5 mg early afternoon, educated on stress dosing for illness, and instructed to wear a medical alert tag. At 4‑month follow‑up, morning cortisol rises to 8 µg/dL and symptoms resolve, allowing taper.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, https://doi.org/10.1210/jc.2015-1818

TODO: consider adding scripts/calc.py for the es-cushing-glucocorticoid-replacement-education-hypocortisolemic calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する